Optimal cutoff points for HOMA-IR and QUICKI in the diagnosis of metabolic syndrome and non-alcoholic fatty liver disease: A population based study

Journal of Diabetes and its Complications

Volumn 30, Issue 2, 2016, Pages 269-274

  Motamed, Nima ^a   Miresmail, Seyed Javad Haji ^b   Rabiee, Behnam ^c   Keyvani, Hossein ^d   Farahani, Behzad ^c   Maadi, Mansooreh ^c   Zamani, Farhad ^c  

^a ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diagnostic index; Homeostatic model assessment index; Metabolic syndrome; Non alcoholic fatty liver disease; Quantitative insulin sensitivity check index

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASSESSMENT OF HUMANS; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTATIC MODEL ASSESSMENT INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; IRAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; YOUDEN INDEX; ADOLESCENT; AGED; CHILD; ENDOCRINE SYSTEM EXAMINATION; METABOLISM; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; REFERENCE VALUE; STANDARDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COHORT STUDIES; DIAGNOSTIC TECHNIQUES, ENDOCRINE; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; REFERENCE VALUES; ROC CURVE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84950336230     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2015.11.019     Document Type: Article

References (29)

1. J.M. Argiles, and F.J. Lopez-Soriano Insulin and cancer (review) International Journal of Oncology 18 4 2001 683 687
2. H. Chen, G. Sullivan, and M.J. Quon Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model Diabetes 54 7 2005 1914 1925
3. J.C. Cohen, J.D. Horton, and H.H. Hobbs Human fatty liver disease: Old questions and new insights Science 332 6037 2011 1519 1523 10.1126/science.1204265
4. K. Cusi Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: Pathophysiology and clinical implications Gastroenterology 142 4 2012 711 725 10.1053/j.gastro.2012.02.003 [e6]
5. A. Delavari, M.H. Forouzanfar, S. Alikhani, A. Sharifian, and R. Kelishadi First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: The national survey of risk factors for noncommunicable diseases of Iran Diabetes Care 32 6 2009 1092 1097 10.2337/dc08-1800
6. J.K. Dowman, J.W. Tomlinson, and P.N. Newsome Systematic review: The diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis Alimentary Pharmacology & Therapeutics 33 5 2011 525 540 10.1111/j.1365-2036.2010.04556.x
7. M.H. Duncan, B.M. Singh, P.H. Wise, G. Carter, and J. Alaghband-Zadeh A simple measure of insulin resistance Lancet 346 8967 1995 120 121
8. R.H. Eckel, S.M. Grundy, and P.Z. Zimmet The metabolic syndrome Lancet 365 9468 2005 1415 1428 10.1016/S0140-6736(05)66378-7
9. E. Fabbrini, S. Sullivan, and S. Klein Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications Hepatology 51 2 2010 679 689 10.1002/hep.23280
10. E.S. Ford, W.H. Giles, and W.H. Dietz Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey JAMA: the journal of the American Medical Association 287 3 2002 356 359
11. M. Gaggini, M. Morelli, E. Buzzigoli, R.A. DeFronzo, E. Bugianesi, and A. Gastaldelli Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease Nutrients 5 5 2013 1544 1560 10.3390/nu5051544
12. P. Gayoso-Diz, A. Otero-Gonzalez, M.X. Rodriguez-Alvarez, F. Gude, F. Garcia, and A. De Francisco A.G. Quintela Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: Effect of gender and age: EPIRCE cross-sectional study BMC Endocrine Disorders 13 2013 47 10.1186/1472-6823-13-47
13. K. Hajian-Tilaki Metabolic syndrome and its associated risk factors in Iranian adults: A systematic review Caspian journal of internal medicine 6 2 2015 51 61
14. J. Hrebicek, V. Janout, J. Malincikova, D. Horakova, and L. Cizek Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention The Journal of Clinical Endocrinology and Metabolism 87 1 2002 144 147 10.1210/jcem.87.1.8292
15. F.R. Jornayvaz, and G.I. Shulman Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance Cell Metabolism 15 5 2012 574 584 10.1016/j.cmet.2012.03.005
16. S. Lillioja, D.M. Mott, M. Spraul, R. Ferraro, J.E. Foley, and E. Ravussin C. Bogardus Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus Prospective studies of Pima Indians, The New England Journal of Medicine 329 27 1993 1988 1992 10.1056/NEJM199312303292703
17. R. Lomonaco, C. Ortiz-Lopez, B. Orsak, A. Webb, J. Hardies, and C. Darland K. Cusi Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease Hepatology 55 5 2012 1389 1397 10.1002/hep.25539
18. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 7 1985 412 419
19. J.B. Meigs, M.A. Mittleman, D.M. Nathan, G.H. Tofler, D.E. Singer, and P.M. Murphy-Sheehy P.W. Wilson Hyperinsulinemia, hyperglycemia, and impaired hemostasis: The Framingham Offspring Study JAMA: the journal of the American Medical Association 283 2 2000 221 228
20. N. Motamed, S. Razmjou, G. Hemmasi, M. Maadi, and F. Zamani Lipid accumulation product and metabolic syndrome: A population-based study in northern Iran, Amol Journal of Endocrinological Investigation 2015 10.1007/s40618-015-0369-5
21. D.M. Muoio, and C.B. Newgard Mechanisms of disease: Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes Nature Reviews Molecular Cell Biology 9 3 2008 193 205 10.1038/nrm2327
22. G.M. Reaven Banting lecture 1988. Role of insulin resistance in human disease Diabetes 37 12 1988 1595 1607
23. A.L. Salgado, L. Carvalho, A.C. Oliveira, V.N. Santos, J.G. Vieira, and E.R. Parise Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals Arquivos de Gastroenterologia 47 2 2010 165 169
24. A.J. Sanyal, C. Campbell-Sargent, F. Mirshahi, W.B. Rizzo, M.J. Contos, and R.K. Sterling J.N. Clore Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 5 2001 1183 1192 10.1053/gast.2001.23256
25. P.A. Sarafidis, A.N. Lasaridis, P.M. Nilsson, M.I. Pikilidou, P.C. Stafilas, and A. Kanaki G.L. Bakris Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type 2 diabetes Journal of Human Hypertension 21 9 2007 709 716 10.1038/sj.jhh.1002201
26. Y. Singh, M.K. Garg, N. Tandon, and R.K. Marwaha A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents Journal of Clinical Research in Pediatric Endocrinology 5 4 2013 245 251 10.4274/Jcrpe.1127
27. B. Singh, and A. Saxena Surrogate markers of insulin resistance: A review World journal of diabetes 1 2 2010 36 47 10.4239/wjd.v1.i2.36
28. C.M. Taniguchi, B. Emanuelli, and C.R. Kahn Critical nodes in signalling pathways: Insights into insulin action Nature Reviews Molecular Cell Biology 7 2 2006 85 96 10.1038/nrm1837
29. F. Zamani, M. Sohrabi, A. Alipour, N. Motamed, F.S. Saeedian, and R. Pirzad M. Khonsari Prevalence and risk factors of cholelithiasis in Amol city, northern Iran: A population based study Archives of Iranian Medicine 17 11 2014 750 754 http://dx.doi.org/0141711/AIM.006